22
Views
15
CrossRef citations to date
0
Altmetric
Original

Palliative Chemotherapy in Pretreated Patients with Advanced Cancer: Oral Trofosfamide Is Effective in Ovarian Carcinoma

, M.D., , M.D., , M.D., , M.D. & , M.D.
Pages 808-811 | Published online: 30 Nov 2001

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jing Zhang, Quan Tian, Sui Yung Chan, Shu Chuen Li, Shufeng Zhou, Wei Duan & Yi-Zhun Zhu. (2005) Metabolism and Transport of Oxazaphosphorines and the Clinical Implications. Drug Metabolism Reviews 37:4, pages 611-703.
Read now

Articles from other publishers (14)

Hanno M. Witte, Armin Riecke, Thomas Mayer, Tobias Bartscht, Dirk Rades, Hendrik Lehnert, Hartmut Merz, Sebastian Fetscher, Harald Biersack & Niklas Gebauer. (2018) Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology 145:1, pages 129-136.
Crossref
Andreas Pircher, Normann Steiner & Eberhard Gunsilius. 2019. Tumor Angiogenesis. Tumor Angiogenesis 327 347 .
Sarika N. Rao & Mouhammed Amir Habra. 2017. Management of Adrenal Masses in Children and Adults. Management of Adrenal Masses in Children and Adults 257 275 .
Andreas Pircher, Normann Steiner & Eberhard Gunsilius. 2017. Tumor Angiogenesis. Tumor Angiogenesis 1 22 .
Matthias Kroiss, Timo Deutschbein, Wiebke Schlötelburg, Cristina L. Ronchi, Bruno Neu, Hans-Helge Müller, Marcus Quinkler, Stefanie Hahner, Anke Heidemeier & Martin Fassnacht. (2016) Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide. Hormones and Cancer 7:3, pages 211-218.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 212 .
Duan Wang & Hongbing Wang. (2012) Oxazaphosphorine bioactivation and detoxification: the role of xenobiotic receptors. Acta Pharmaceutica Sinica B 2:2, pages 107-117.
Crossref
Deborah Armstrong. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1827 1855 .
T. Klink, C. Bela, S. Stoelting, S. O. Peters, R. Broll & T. Wagner. (2006) Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects. Journal of Cancer Research and Clinical Oncology 132:10, pages 643-652.
Crossref
Yago Nieto. 2005. 163 203 .
D. Latz, N. Nassar & R. Frank. (2004) Trofosfamide in the Palliative Treatment of Cancer: A Review of the Literature. Oncology Research and Treatment 27:6, pages 572-576.
Crossref
S.-E. Al-Batran, A. Atmaca, F. Bert, D. Jäger, C. Frisch, A. Neumann, J. Orth, A. Knuth & E. Jäger. (2004) Dose Escalation Study for Defining the Maximum Tolerated Dose of Continuous Oral Trofosfamide in Pretreated Patients with Metastatic Lung Cancer. Oncology Research and Treatment 27:6, pages 534-538.
Crossref
Thomas Vogt, Christian Hafner, Klaus Bross, Frauke Bataille, Karl-Walter Jauch, Anna Berand, Michael Landthaler, Reinhard Andreesen & Albrecht Reichle. (2003) Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer 98:10, pages 2251-2256.
Crossref
Yago Nieto. 2003. 171 209 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.